Papers
1
Total Citations
21
H-Index
1
About
F. Midili is a radiation oncologist whose research focuses on advancing stereotactic body radiotherapy (SBRT) for prostate cancer treatment. Their most cited work, "High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer" (2015, 21 citations), investigates how SBRT can emulate high-dose-rate brachytherapy dose fractionation. Midili's major contribution lies in demonstrating the feasibility of using robotic SBRT both as monotherapy and as a pre-external-beam radiotherapy boost for localized prostate cancer, offering a non-invasive alternative to traditional brachytherapy. This work has helped establish SBRT as a precise, high-dose treatment option that reduces treatment duration while maintaining efficacy. Though their citation count is modest, Midili's research addresses a critical need in prostate cancer management—balancing tumor control with quality of life. Their findings have informed clinical protocols for integrating SBRT into standard care, particularly for patients seeking shorter, less invasive treatment courses. Midili's work continues to influence ongoing studies in hypofractionated radiotherapy and image-guided radiation delivery.
Research Focus
Key Achievements
Top Papers
- 1